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The requirement for supplementary oxygen (0,) after fibre-optic bronchoscopy (FOB) was evaluated by means of 
pulse oximetry in 34 patients (19 men) of median age 62 years (range 28-85) who had had a diagnostic FOB. The 
patients were allocated at random into two groups, each of 17 persons, which were comparable concerning sex, age 
and the dose of benzodiazepine (diazepam tablets 10 mg 1 h before FOB and midazolam 2-5 mg iv. during FOB) 
used for premeditation. Patients in group 1 had lower pulmonary function (FEV, , FVC as a percentage of predicted 
values) than patients in group 2 (PcO.02). The oxygen saturation of the haemoglobin (SpO,) in the tip of the index 
finger was recorded continuously for 30 min after the administration of oral diazepam, during FOB and for 120 min 
after the FOB procedure. All patients received nasal 0, supplement 2 1 min -’ during FOB. After FOB, O2 was 
discontinued in group 1, while group 2 continued to receive 0,2 1 min - r for 120 min. The incidence of hypoxaemic 
episodes (SpO, I 90% for a period of a minimum of 2 12 s) after oral diazepam, before FOB, was similar in the two 
groups, 35%. After FOB, the incidence of hypoxaemic episodes was 88% in group 1 and 41% in group 2 (P<O.Ol). 
The cumulated duration of hypoxaemia after FOB was a median of 30 s (range o-7140) in group 1 and a median of 
0 s (o-156) in group 2 (WO.0001). Impaired lung function (FEV, ~75% of predicted value) was a risk factor for 
hypoxaemia. Postbronchoscopy, 0, supplement should be administered to sedated patients with impaired lung 
function until the patients have fully recovered. 
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Introduction 
Fibre-optic bronchoscopy (FOB) performed in local anaes- 
thesia is an essential diagnostic procedure in the evaluation 
of patients with pulmonary disease (1). During FOB, most 
patients display a moderate fall in the arterial oxygen 
tension (PaO,), while the arterial carbon dioxide tension 
(PaCO,) remains stable (2-4). The pulse oximeter allows 
continuous monitoring of the oxygen saturation of haemo- 
globin in the blood in peripheral tissue (SpO,), which is 
closely correlated to the oxygen saturation in arterial blood 
(SaO,) (56). It has been shown in a previous study using 
pulse oximetry that many patients develop hypoxaemia 
during FOB, and that the incidence of hypoxaemia can be 
reduced by oxygen supplement (7,s). Especially patients 
in a poor general condition, and those with impaired 
pulmonary function, carry a high risk of developing 
hypoxaemia (7). 
As oxygen supplement is not routinely given to patients 
in the initial postbronchoscopy period hypoxaemia may 
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occur in this phase. The purpose of the present study was to 
evaluate the incidence of postbronchoscopy hypoxaemia 
and the effect of oxygen supplement after FOB. 
Patients and Methods 
PATIENTS 
The study, being approved by the local Ethics Committee 
comprised 40 consecutive patients who had an FOB in local 
anaesthesia as part of the diagnostic evaluation. Informed 
consent was obtained in all patients. None of the patients 
had asthma. Bronchodilators were not administered as a 
routine, but patients with chronic obstructive ventilatory 
insufficiency who were on bronchodilators received their 
usual medication 1 h prior to FOB. The patients were 
allocated at random into two groups, each of 20 individ- 
uals. Group 1 received no oxygen supplement in the post- 
bronchoscopy observation period. Group 2 was treated 
with oxygen for 2 h after bronchoscopy. Three subjects in 
each group were excluded due to deviation from the proto- 
col and/or insufficient data records. Pulmonary function 
tests (FEV,, FVC, VC, FEV,/FVC) were performed prior 
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TABLE 1. Clinical data, pulmonary function tests (FEV,, forced expiratory volume in the first second; 
FVC, forced expiratory volume, both in measured values and in percentage of predicted values), 
dose of diazepam administered 1 h before and dose of midazolam administered immediately prior to 
fibre-optic bronchoscopy in local anaesthesia in 34 patients examined with or without postbronchos- 
copy oxygen supplement (figures indicate median and range) 
Oxygen 
supplement 
group 
-0, 
I?=17 
+02 
n=17 
P value* 
Sex Age FEV, FEV, FVC FVC Diazepam Midazolam 
WI W (1) (%I (1) (%) (mgk-‘1 (mgkg-‘1 
62 1.9 65 2.8 80 0.14 0.04 
1017 
41-80 1.1-3.0 47-92 1.84.8 49-106 0~10-0~20 0.02-0.05 
59 2.3 91 3.2 97 0.14 0.03 
9/s 
25-85 1.54.7 46-128 2.3-6.1 45-127 0.10-0.24 o-0.10 
0.9 0.3 0.1 0.02 0.2 0.04 0.9 0.6 
*Mann-Whitney test. 
TABLE 2. Indications for fibre-optic bronchoscopy (FOB) in 
local anaesthesia and diagnostic procedures performed in 
34 patients examined with or without postbronchoscopy 
oxygen supplement (figures indicate number of patients) 
Oxygen FOB indication FOB procedure 
supplement 
group LL DL NL BW BW/BB BWlTBB 
-02 15 1 1 1 2 14 
n=17 
+o* 14 2 1 2 7 8 
n=17 
x2 test: P>O.O5. 
LL, localized pulmonary lesions; DL, diffuse pulmonary 
lesions; NL, bronchopulmonary symptoms with normal 
chest X-ray. Procedures: BW, bronchial washing; BWIBB, 
bronchial washing and bronchial biopsy (BB); BWITBB, 
bronchial washing and transbronchial biopsy (TBB). 
to FOB. Data on the included 34 subjects are shown in 
Table 1. 
FIBRE-OPTIC BRONCHOSCOPY 
The indications for FOB and the procedures performed at 
FOB are listed in Table 2. Premeditation consisted of 
intramuscular atropine 0.5 mg and diazepam tablets of 
10 mg, given 1 h before FOB. Additional sedative, intra- 
venous midazolam up to 4.0 mg, was administered imme- 
diately prior to FOB (Table 1). Local anaesthesia was 
obtained with lidocaine spray in the upper respiratory tract 
and lidocaine solution in the bronchial tree. The total dose 
of lidocaine was below 500 mg in all patients. FOB was 
performed with the Olympus lT20D fibre-optic broncho- 
scope using the transnasal route. Bronchial washing (BW) 
was performed with 2040 ml of isotonic saline. The FOB 
procedure lasted for a median of 18 min (range 8-28). 
There were no complications in terms of pneumothorax or 
excessive bleeding after biopsy. 
PULSE OXIMETRY 
SpO, was measured with a pulse oximeter (0X1, Radiom- 
eter, DK-2200 Copenhagen), using a probe mounted on the 
left index finger. Besides SpOZ, the instrument recorded the 
pulse rate. Cardiac monitoring with ECG was not per- 
formed. SpO, and pulse rate were continuously recorded on 
a paper strip. The pulse oximeter calculated and printed the 
average SpO, in periods of 12 s, i.e. the shortest period of 
hypoxaemia to be recorded was 12 s. In order to estimate 
the accuracy of the instrument, corresponding SpO, values 
from the pulse oximeter and SaO, values measured on a 
hemoximeter (OSM 2 Hemoximeter, Radiometer, DK-2200 
Copenhagen) were compared in 10 patients, and a highly 
significant correlation was found between these two vari- 
ables (~~0.95, P<O.OOOl). Hypoxaemia was defined as 
an SpO, value of <90x, corresponding to a PaO, of 
I 8.0 kPa (5). 
Before FOB, pulse oximetry recordings were available in 
all patients from 0 to 30 min after the administration of 
peroral diazepam. During FOB, only the minimum SpO, 
was recorded. After FOB, recordings were available in all 
patients from 0 to 120 min. 
OXYGEN SUPPLEMENT 
Before and after FOB, oxygen was administered on a 
twin-nasal oxygen cannula with a prong in each nostril 
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TABLE 3. Number of patients with hypoxaemia before and after fibre-optic bronchoscopy (FOB) in 
34 patients with and without post-bronchoscopy oxygen supplement 
Number of patients with hypoxaemia (SpO, 590%) for 2 12 s 
Oxygen After premeditation 
supplement with diazepam (min) 
After FOB (min) 
group O-30 O-60 61-120 O-120 
-02 6117 15/17 11/17 15/17 
n= 17 35.3% 88.2% 64.7% 88.2% 
+02 6117 6117 4117 7117 
it=17 353% 35.3% 23.5% 41.2% 
P value* n.s. 0.004 0.04 0.01 
*x2 test. 
(UnoPlast A/S, DK-3390 Hundested). In all patients, oxy- 
gen2lmin’ was administered during the FOB procedure 
from the insertion to the withdrawal of the bronchoscope; 
this oxygen was delivered through a mono-nasal catheter 
placed with the tip in the vestibulum nasi (Pharma Plast 
A/S. DK-2750 Ballerup) (8). After the termination of FOB, 
oxygen was discontinued in patients in group 1, and 
continued at the same flow of 2 1 min - i in patients in 
group 2. 
STATISTICS 
Due to the skewed distribution of the hypoxaemic episodes, 
differences between groups were evaluated by Mann- 
Whitney’s rank sum test, and the x2 test. A P value of 0.05 
was considered as being significant. 
Results 
The two groups of patients did not differ significantly from 
each other with respect to sex and age (Table 1). The 
indications for FOB and the diagnostic procedures 
performed at FOB were likewise similar in the two groups 
(Table 2). 
HYPOXAEMIA 
Within 30 min of administration of oral diazepam, prior 
to FOB, the incidence of hypoxaemic episodes with SpO, 
590% for 2 12 s were similar in both groups, 35% (Table 
3). 
During FOB, a total of six patients, three in group 1 and 
three in group 2, demonstrated minimum SpO, values of 
I90%. 
Within 120 min after FOB, 88% of the patients in group 
1 rs. 41% of the patients in group 2 (P<O.Ol) had one or 
more hypoxaemic episodes. The total accumulated mean 
duration of hypoxaemia before and in different periods 
after FOB are shown in Fig 1. The duration of post- 
bronchoscopy hypoxaemia was significantly higher in 
patients in group 1 than in those of group 2. The accumu- 
lated duration of hypoxaemia before and after FOB in the 
two groups and subgroups are shown in Table 4. 
PREMEDICATION 
The dose of benzodiazepine in mg kg body weight was not 
significantly different in the two groups (Table 1). 
PULMONARY FUNCTION 
Pulmonary function was significantly lower in group 1 than 
in group 2 (Table 1): four patients (two in group 1 and two 
in group 2) had an FEV,<SO% of predicted value. These 
patients had arterial blood gases within the normal range. 
In order to evaluate the influence of pulmonary function, 
the patients were stratified according to FEV, (FEV, 2 75% 
and FEV, ~75% of predicted value). Nineteen patients had 
an FEV, of ~75% of predicted (12 patients in group 1 and 
seven patients in group 2). In group 1, the total duration of 
postbronchoscopy hypoxaemia was higher in patients with 
impaired pulmonary function, but the difference was not 
statistically significant (Table 4). In group 2, there was no 
difference in the duration of postbronchoscopy hypoxaemia 
whether the patients had normal or impaired pulmonary 
function. 
Of the 19 patients with impaired pulmonary function, 
10 had FEV,/FVC ratios of ~0.70, compatible with an 
obstructive lung disease, six had ratios of 0.70-0.80, and 
three patients had ratios of >0.80, compatible with a 
restrictive lung disease. There was no significant difference 
between the FEV,/FVC ratio in group 1 and group 2 
patients. 
PULSE RATE 
In five patients displaying nine episodes of hypoxaemia 
with SpO, of 82-89%, the pulse rate increased from 
r 
Before FOB 
After FOB 
0 12-120 >120 
Duration of hypoxaemia (s) 
FIG. 1. Duration of hypoxaemia (SpO, 190%) in 34 
patients before and after fibre-optic bronchoscopy in local 
anaesthesia. Before bronchoscopy, no oxygen supplement 
was given. During bronchoscopy, oxygen 2 1 min ~ i was 
given to all patients. After bronchoscopy, oxygen was dis- 
continued in patients in group 1 (n = 17) whereas patients 
in group 2 (n = 17) continued to have oxygen 2 1 min - ’ 
Solid bars, oxygen; open bars, no oxygen. 
baseline values of 60-100 min - ’ to maximum values of 
108-130 min- ‘. 
DURATION OF BRONCHOSCOPY 
In group 1 patients, the FOB lasted for a median of 
18 min (range 10-25) and in group 2 patients for a 
median of 14 min (range 8-28) (P~0.06). There was no 
bronchoscopy bleeding, and no postbronchoscopy 
pneumothorax. 
Discussion 
Since the pulse oximeter became commercially available, 
the option to perform continuous monitoring of the oxygen 
saturation in blood has increased our understanding of the 
procedures and disease processes associated with hypoxae- 
mia (5,6). The pulse oximeter is being used to an increasing 
extent for patient surveillance where hypoxaemia may be 
encountered, for example, general anaesthesia and endo- 
scopic diagnostic or therapeutic procedures performed 
during sedation (5,6). 
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Detrimental effects of hypoxaemia on cerebral and car- 
diac function should be avoided in association with FOB by 
maintaining the SpO, level above 90%, corresponding to a 
PaO, level of 8.0 kPa. Four peribronchoscopy phases 
can be recognized: 1, before premeditation; 2, after oral 
premeditation with benzodiazepine; 3, during FOB; and 4, 
after FOB. 
Prior to FOB, treatment with bronchodilators and anti- 
asthmatics should be optimized. In this phase, the SpO, 
level and the incidence of hypoxaemia depend on pulmon- 
ary function. In patients with respiratory insufficiency and a 
Pa0,<8.0 kPa, and especially in patients with an elevated 
PaCO,, the indication for FOB should be reconsidered, 
and appropriate measures taken to ensure adequate 
oxygenation and avoidance of hypercapnia during the 
procedure. 
In the phase following oral premeditation, prior to the 
FOB procedure, the degree and duration of hypoxaemia 
depends on both the pulmonary function as well as the 
respiratory depressive effect of benzodiazepine. Among our 
patients, 8119 (42%) with impaired and 4/15 (27%) with 
normal lung function had at least one hypoxaemic episode 
lasting for at least 12 s in the 30 min period following oral 
premeditation. In total, 35% of the patients had hypoxae- 
mic episodes. In a previous series comprising 81 patients, a 
similar percentage, 35%, had hypoxaemic episodes immedi- 
ately prior to FOB (7), and in another series comprising 120 
patients the corresponding figure was 37% (8). These results 
indicate that supplementary oxygen should be started con- 
comitantly with oral premeditation if hypoxaemia is to be 
avoided prior to FOB. 
During the FOB procedure, when the bronchoscope is 
within the respiratory tract, there is an average decline in 
PaO, of 2.5 kPa (24), and in SpO, of 1% (8). The decline 
is observed in all patients, being independent of pulmonary 
function, prebronchoscopy PaO,, and premeditation (9). 
The decline can be converted into a rise in SpO, of l-3% 
during FOB if supplementary oxygen is given (7,8). The 
decline in SpO, is accentuated by suction through the 
bronchoscope and by bronchoalveolar lavage (BAL) 
(24,lO). In this series, BAL was not performed. However, 
patients with impaired pulmonary function not having 
oxygen supplement display a higher incidence of hypoxae- 
mia than do patients with normal lung function (7). Oxygen 
supplement 2 1 min - ’ markedly reduces the incidence and 
degree of hypoxaemia (7,8). 
In the postbronchoscopy phase the decline in SpO, and 
PaO, observed during the FOB procedure persists for a 
considerable period. In two previous studies, prebronchos- 
copy SpO, levels were not attained during a 10 min post- 
bronchoscopy observation period (7,8), and in another 
study prebronchoscopy PaO, levels were reached after 1 h 
in 50% and after 2 h in 75% of the patients (4). 
A high incidence of postbronchoscopy hypoxaemic 
episodes (88%) was observed in patients not receiving 
supplementary oxygen (Table 3). The incidence decreased 
with the time elapsed after the procedure. Patients 
having oxygen supplement displayed an incidence of 
hypoxaemic episodes of 41%, i.e. still of considerable 
magnitude. The total accumulated duration of hypoxaemia 
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TABLE 4. Accumulated total duration of hypoxaemia before and after fibre-optic bronchoscopy 
(FOB) in 34 patients with and without postbronchoscopy oxygen supplement. Patients are divided in 
subgroups according to lung function (FEV, in percent of predicted value). Figures indicate median 
and range 
Duration of hypoxaemia (SpO, I 90%) (s) 
Oxygen After premeditation 
supplement with diazepam (min) 
group O-30 O-30 
After FOB (min) 
31-60 61-90 91-120 O-120 
-0, 
1 All patients 
n=17 
3 FEV, 275% 
n=5 
P value* 
5 FEV, ~75% 
n=12 
+02 
2 All patients 
n=17 
4 FEV, 275% 
n=lO 
P value* 
6 FEV, ~75% 
n=7 
P value 1 vs. 2* 
P value 3 vs. 4* 
P value 5 vs. 6* 0.14 0.01 
0 48 36 12 24 
O-1452 O-1740 O-1800 O-1800 O-1800 
12 12 12 0 0 
O-132 o-252 O-216 O-24 O-36 
n.s. n.s. n.s. n.s. n.s. 
0 48 54 54 30 
O-1452 O-1740 O-1800 O-1800 O-1800 
0 0 0 0 0 0 
O-1560 O-72 @36 048 o-24 O-156 
0 0 0 0 0 0 
O-300 o-72 O-36 048 O-24 O-156 
0.02 ns. n.s. ns. ns. ns. 
48 0 0 0 0 0 
O-1560 O-36 O-36 o-12 O-0 048 
0.22 
0.10 
0.001 
0.21 
0.001 
0.14 
0.01 
0.001 
0.95 
0.01 
0.001 
0.19 
0.01 
156 
O-7140 
72 
O-468 
2”;; . 
O-7140 
0.0003 
0.11 
0.003 
*Mann-Whitney test. 
n.s. =not significant. 
was distinctly higher in group 1 patients not having oxygen 
(Table 4). Patients in group 1 with impaired lung function 
(FEV,<75% of predicted) had the longest duration 
of hypoxaemia, but the difference was not statistically 
significant, due probably to the small number of patients. 
The sedative effect of oral diazepam given 1 h prior to 
FOB reaches its maximum about 0.551 h after admin- 
istration and lasts for 24 h. The sedative effect of intra- 
venous midazolam given at the beginning of FOB may, 
depending on the dose and the susceptibility of the patient, 
last for a median of 10 min, range 540 min after FOB (11). 
Furthermore, midazolam appears to induce a more pro- 
nounced respiratory depression in patients with chronic 
obstructive pulmonary disease than in normal subjects (12). 
Hypoxaemia could also be explained by a mismatching 
of ventilation and perfusion due to bronchial obstruction. 
This issue could be solved only by a parallel measurement 
of PaCO, - which should rise in respiratory depression and 
remain stable in mild bronchial obstruction. We did not 
record PaCO,, but other authors have reported that the fall 
in PaO, during and after FOB is not accompanied by a rise 
in PaCO, (24). 
In conclusion, the present results as well as the observa- 
tions from previous studies indicate that supplementary 
oxygen should be considered concomitantly with the 
premeditation in order to avoid hypoxaemia prior to FOB. 
Furthermore, in patients with impaired pulmonary func- 
tion, the results demonstrate the need for postbronchos- 
copy oxygen supplement and monitoring with pulse 
oximetry, which should continue until the patient has fully 
recovered from the sedation. 
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